0.0000
0.0000
(0.00%)
At close: February 12 at 3:00:00 PM EST
Breakdown
TTM
12/31/2022
Operating Cash Flow
--
-3,429.2050
Investing Cash Flow
--
-239.0530
Financing Cash Flow
--
1,225.4620
End Cash Position
--
23.7940
Capital Expenditure
--
-36.3460
Issuance of Debt
--
740.0740
Repayment of Debt
--
-17.9820
Free Cash Flow
--
-3,465.5510
12/31/2022 - 1/13/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RGBPP Regen BioPharma, Inc.
0.0651
0.00%
XRTX XORTX Therapeutics Inc.
0.9600
+2.13%
SNSE Sensei Biotherapeutics, Inc.
0.4850
+3.54%
BNTC Benitec Biopharma Inc.
9.70
-4.90%
OABI OmniAb, Inc.
3.6400
+1.96%
PSTV Plus Therapeutics, Inc.
1.2000
+7.14%
CELC Celcuity Inc.
12.62
+1.69%
LENZ LENZ Therapeutics, Inc.
25.28
+1.77%
LVTX LAVA Therapeutics N.V.
0.9320
-0.85%
PVLA Palvella Therapeutics, Inc.
20.00
+18.48%